1. Home
  2. LILA vs SDGR Comparison

LILA vs SDGR Comparison

Compare LILA & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Latin America Ltd.

LILA

Liberty Latin America Ltd.

N/A

Current Price

$8.11

Market Cap

1.6B

ML Signal

N/A

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

N/A

Current Price

$27.36

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LILA
SDGR
Founded
2017
1990
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
LILA
SDGR
Price
$8.11
$27.36
Analyst Decision
Hold
Buy
Analyst Count
4
7
Target Price
$10.55
★ $21.43
AVG Volume (30 Days)
297.0K
★ 3.0M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
7.55
★ 45.14
EPS
★ N/A
N/A
Revenue
★ $4,442,200,000.00
$255,869,000.00
Revenue This Year
$0.92
N/A
Revenue Next Year
$3.13
$3.12
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 23.29
52 Week Low
$4.77
$10.95
52 Week High
$9.04
$33.78

Technical Indicators

Market Signals
Indicator
LILA
SDGR
Relative Strength Index (RSI) 39.96 52.63
Support Level $7.10 $11.27
Resistance Level $8.16 $31.59
Average True Range (ATR) 0.27 2.17
MACD -0.02 -0.67
Stochastic Oscillator 4.35 20.64

Price Performance

Historical Comparison
LILA
SDGR

About LILA Liberty Latin America Ltd.

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: